封面
市场调查报告书
商品编码
1441469

生命科学软体市场规模 - 类型、应用、组件、解决方案 - 区域展望、竞争策略、细分市场预测(~2033 年)

Life Science Software Market Size- By Type, By Application, By Component, By Solutions - Regional Outlook, Competitive Strategies and Segment Forecast to 2033

出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 234 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

到 2033 年,生命科学软体市场规模预计将成长至 647.1 亿美元,预测期内复合年增长率为 13.11%。

全球生命科学软体市场受到 COVID-19 爆发的严重影响。开发针对这种病毒的治疗方法和疫苗的迫切需求正在推动对支持药物发现、基因组学和临床试验的软体解决方案的需求。由于面对面会议的禁止,需要远端工作和协作工具,这促使人们采用云端基础的平台和线上协作工具。

该报告调查了全球生命科学软体市场,并提供了市场概况、市场影响因素和市场机会分析、市场规模趋势和预测、各个细分市场和地区的详细分析、竞争形势以及主要企业。总结的。

目录

第一章简介

第二章调查方法

第三章执行摘要

第四章市场动态

  • 驱动因素、限制因素、机会与挑战分析
  • COVID-19 对市场的影响

第五章 市场变数与展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 热图分析

第六章 竞争形势

  • 製造地、销售区域、产品类型分布
  • 併购、联盟、产品发布、合作

第七章全球生命科学软体市场:依类型

  • 全球市占率及预测
  • 说明的
  • 预测性的
  • 规定性的

第八章全球生命科学软体市场:依应用分类

  • 全球市占率及预测
  • 遵守
  • 行销
  • R&D
  • 药物安全检测
  • SCM

第九章全球生命科学软体市场:按组成部分

  • 全球市占率及预测
  • 软体
  • 服务

第10章全球生命科学软体市场:按解决方案

  • 全球市占率及预测
  • 云端基础
  • 本地

第十一章全球生命科学软体市场预测

  • 市场规模/市场占有率趋势/预测

第十二章全球生命科学软体市场:按类型

  • 市场规模/市场占有率趋势/预测

第十三章全球生命科学软体市场:依应用分类

  • 市场规模/市场占有率趋势/预测

第 14 章全球生命科学软体市场:按组成部分

  • 市场规模/市场占有率趋势/预测

第十五章全球生命科学软体市场:按解决方案

  • 市场规模/市场占有率趋势/预测

第十六章全球生命科学软体市场:按地区

  • 市场规模/市场占有率趋势/预测
  • 亚太地区
  • 欧洲
  • 中东/非洲
  • 北美洲
  • 拉丁美洲

第十七章 公司简介

  • Allscripts Healthcare LLC
  • Cerner Corporation
  • Cognizant
  • CPSI
  • Elinext
  • EPIC System Corporation
  • INFOR
  • Jag Products LLC
  • Meta
  • Oracle
  • 其他的

第十八章简称表

第十九章 参考链接

第20章结论

第二十一章 研究范围

简介目录
Product Code: IACT2434

Life Science Software Market Introduction and Overview

According to SPER market research, 'Life Science Software Market - By Type, By Application, By Component, By Solution- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Life Science Software Market is predicted to reach USD 64.71 billion by 2033 with a CAGR of 13.11%.

Life science software includes a range of tools for standardizing workflow and document management in the biopharmaceutical, medical technology, generics, and clinical care sectors. These programs allow businesses to capture, store, and preserve data using images and text. There are various types of life science software available, such as drug identification and validation, laboratory management, clinical trial management, and medical device development.

Furthermore, the global market for life science software has been significantly affected by the COVID-19 pandemic. Because of the urgency of developing treatments and vaccines for the virus, there is an increased demand for software solutions that aid in drug discovery, genomics, and clinical trials. The ban on in-person meetings necessitated remote work and collaboration tools, hastening the adoption of cloud-based platforms and online collaboration tools.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Type, By Application, By Component, By Solution

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Allscripts Healthcare LLC, Cerner Corporation , Cognizant, CPSI , Elinext , EPIC Systems Corporation, INFOR, Jag products LLC ,Meta, Oracle

Global Life Science Software Market Segmentation:

By Type: Based on the Type, Global Life Science Software Market is segmented as; Descriptive, Predictive and Prescriptive.

By Application: Based on the Application, Global Life Science Software Market is segmented as; Compliance, Marketing, R & D, Pharmacovigilance and SCM.

By Component: Based on the Component, Global Life Science Software Market is segmented as; Software and Services.

By Solutions: Based on the Solutions, Global Life Science Software Market is segmented as; Cloud- Based and On- Premises.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Global Life Science Software Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Life Science Software Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Life Science Software Market

7. Global Life Science Software Market, By Type (USD Million)

  • 7.1. Global Life Science Software Market Value Share and Forecast, By Type, 2024-2033
  • 7.2. Descriptive
  • 7.3. Predictive
  • 7.4. Prescriptive

8. Global Life Science Software Market, By Application (USD Million)

  • 8.1. Global Life Science Software Market Value Share and Forecast, By Application, 2024-2033
  • 8.2. Compliance
  • 8.3. Marketing
  • 8.4. R &D
  • 8.5. Pharmacovigilance
  • 8.6. SCM

9. Global Life Science Software Market, By Component (USD Million)

  • 9.1. Global Life Science Software Market Value Share and Forecast, By Component, 2024-2033
  • 9.2. Software
  • 9.3. Services

10. Global Life Science Software Market, By Solution (USD Million)

  • 10.1. Global Life Science Software Market Value Share and Forecast, By Solution, 2024-2033
  • 10.2. Cloud- Based
  • 10.3. On- Premises

11. Global Life Science Software Market Forecast, 2020-2033 (USD Million)

  • 11.1. Global Life Science Software Market Size and Market Share

12. Global Life Science Software Market, By Type, 2020-2033 (USD Million)

  • 12.1. Global Life Science Software Market Size and Market Share By Type (2020-2026)
  • 12.2. Global Life Science Software Market Size and Market Share By Type (2027-2033)

13. Global Life Science Software Market, By Application, 2020-2033 (USD Million)

  • 13.1. Global Life Science Software Market Size and Market Share By Application (2020-2026)
  • 13.2. Global Life Science Software Market Size and Market Share By Application (2027-2033)

14. Global Life Science Software Market, By Component, 2020-2033 (USD Million)

  • 14.1. Global Life Science Software Market Size and Market Share By Component (2020-2026)
  • 14.2. Global Life Science Software Market Size and Market Share By Component (2027-2033)

15. Global Life Science Software Market, By Solution, 2020-2033 (USD Million)

  • 15.1. Global Life Science Software Market Size and Market Share By Solution (2020-2026)
  • 15.2. Global Life Science Software Market Size and Market Share By Solution (2027-2033)

16. Global Life Science Software Market, By Region, 2020-2033 (USD Million)

  • 16.1. Global Life Science Software Market Size and Market Share By Region (2020-2026)
  • 16.2. Global Life Science Software Market Size and Market Share By Region (2027-2033)
  • 16.3. Asia-Pacific
    • 16.3.1. Australia
    • 16.3.2. China
    • 16.3.3. India
    • 16.3.4. Japan
    • 16.3.5. South Korea
    • 16.3.6. Rest of Asia-Pacific
  • 16.4. Europe
    • 16.4.1. France
    • 16.4.2. Germany
    • 16.4.3. Italy
    • 16.4.4. Spain
    • 16.4.5. United Kingdom
    • 16.4.6. Rest of Europe
  • 16.5. Middle East and Africa
    • 16.5.1. Kingdom of Saudi Arabia
    • 16.5.2. United Arab Emirates
    • 16.5.3. Rest of Middle East & Africa
  • 16.6. North America
    • 16.6.1. Canada
    • 16.6.2. Mexico
    • 16.6.3. United States
  • 16.7. Latin America
    • 16.7.1. Argentina
    • 16.7.2. Brazil
    • 16.7.3. Rest of Latin America

17. Company Profile

  • 17.1. Allscripts Healthcare LLC
    • 17.1.1. Company details
    • 17.1.2. Financial outlook
    • 17.1.3. Product summary
    • 17.1.4. Recent developments
  • 17.2. Cerner Corporation
    • 17.2.1. Company details
    • 17.2.2. Financial outlook
    • 17.2.3. Product summary
    • 17.2.4. Recent developments
  • 17.3. Cognizant
    • 17.3.1. Company details
    • 17.3.2. Financial outlook
    • 17.3.3. Product summary
    • 17.3.4. Recent developments
  • 17.4. CPSI
    • 17.4.1. Company details
    • 17.4.2. Financial outlook
    • 17.4.3. Product summary
    • 17.4.4. Recent developments
  • 17.5. Elinext
    • 17.5.1. Company details
    • 17.5.2. Financial outlook
    • 17.5.3. Product summary
    • 17.5.4. Recent developments
  • 17.6. EPIC System Corporation
    • 17.6.1. Company details
    • 17.6.2. Financial outlook
    • 17.6.3. Product summary
    • 17.6.4. Recent developments
  • 17.7. INFOR
    • 17.7.1. Company details
    • 17.7.2. Financial outlook
    • 17.7.3. Product summary
    • 17.7.4. Recent developments
  • 17.8. Jag Products LLC
    • 17.8.1. Company details
    • 17.8.2. Financial outlook
    • 17.8.3. Product summary
    • 17.8.4. Recent developments
  • 17.9. Meta
    • 17.9.1. Company details
    • 17.9.2. Financial outlook
    • 17.9.3. Product summary
    • 17.9.4. Recent developments
  • 17.10. Oracle
    • 17.10.1. Company details
    • 17.10.2. Financial outlook
    • 17.10.3. Product summary
    • 17.10.4. Recent developments
  • 17.11. Others

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope